Achillion Pharmaceuticals Inc $11.57

up +0.12


29/8/2014 04:04 PM  |  NASDAQ : ACHN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ACHN Trend Analysis - it has outperformed the S&P 500 by 55%

Partner Headlines

  1. Four biotech takeover targets?

    IBD
  2. 4 Biotechs That Might Be Bought Soon

    IBD
  3. Deutsche Bank Sees Achillion, Arrowhead As Potential Takeover Targets

    Benzinga
  4. Morning Market Movers

    Benzinga
  5. Benzinga's Top #PreMarket Gainers

    Benzinga
  6. Benzinga's M&A Chatter for Monday August 25, 2014

    Benzinga
  7. Achillion Shares Spike Higher, Near $11 As UBS Analyst Sees Possibility ...

    Benzinga
  8. Weekly CEO Sells Highlight: Achillion Pharmaceutical Inc, Protective Life ...

    GuruFocus
  9. Benzinga's Top #PreMarket Losers

    Benzinga
  10. ACHILLION PHARMA

    IBD
  11. UPDATE: Achillion Has Received US Patent for ACH-3102, Structurally-Related ...

    Benzinga
  12. Achillion Pharmaceuticals

    IBD
  13. Achillion Pharmaceuticals Up On Buyout Rumors

    IBD
  14. Dow Surges 175 Points; Fabrinet Shares Slide

    Benzinga
  15. Markets Open Higher; Dollar General Offers $9.7 Billon To Buy Family Dollar

    Benzinga
  16. Morning Market Movers

    Benzinga
  17. Deutsche Bank Raises Achillion Price Target 183%

    Benzinga
  18. Benzinga's Top #PreMarket Gainers

    Benzinga
  19. Gilead Wins Sovaldi Ruling

    IBD
  20. Biotech Leader Gilead Sciences Scores Sovaldi Win

    IBD
  21. Markets Close The Week On Negative Note As Ukraine Worries Mount

    Benzinga
  22. U.S. Stocks Turn Lower; Dillard's Shares Slide On Downbeat Earnings

    Benzinga
  23. Gilead Wins Sovaldi Dispute With Roche, U.K. Nod

    IBD
  24. Markets Gain; J.C. Penney Posts Narrower-Than-Expected Q2 Loss

    Benzinga
  25. Stocks Hitting 52-Week Highs

    Benzinga
  26. Morning Market Movers

    Benzinga
  27. Benzinga's Top #PreMarket Gainers

    Benzinga
  28. Morning Market Movers

    Benzinga
  29. Benzinga's Top Upgrades

    Benzinga
  30. Piper Jaffray Upgrades Achillion Pharmaceuticals To Overweight

    Benzinga
  31. Benzinga's Top #PreMarket Gainers

    Benzinga
  32. Exclusive: Enanta Pharmaceuticals CEO Jay Luly Discusses Hep C Pipeline

    Benzinga
  33. Exclusive: Hepatitis C Stock Valuation With Enanta CEO Jay Luly

    Benzinga
  34. Achillion

    IBD
  35. Achillion Could Win Idenix's Mystery Suitor: Analyst

    IBD
  36. Baird Comments On Achillion's Bullish Share Action

    Benzinga
  37. Benzinga's Top #PreMarket Losers

    Benzinga
  38. Benzinga's Top #PreMarket Losers

    Benzinga
  39. Achillion Gets Massive Price Target Hike On HCV Drugs

    IBD
  40. Achillion gets price target hike

    IBD
  41. Mid-Day Market Movers For Monday, June 16, 2014

    Benzinga
  42. Achillion Gets Massive Price Target Hike On HCV Drugs

    IBD
  43. Morning Market Movers

    Benzinga
  44. Maxim Group Significantly Raises Achillion's PT, Shares Soar +15%

    Benzinga
  45. Mid-Afternoon Market Update: Markets Reverse Early Loses; Oil Continues ...

    Benzinga
  46. Mid-Morning Market Update: Markets Mostly Flat; Priceline To Acquire OpenTable ...

    Benzinga
  47. Morning Market Losers

    Benzinga
  48. Benzinga's Top #PreMarket Losers

    Benzinga
  49. Benzinga's Top Upgrades

    Benzinga
  50. FDA lifts hold, Achillion soars

    IBD
Trading Center